Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Double blind clinical trial on centperazine & DEC in bancroftian filariasis.

Identifieur interne : 00DA35 ( Main/Curation ); précédent : 00DA34; suivant : 00DA36

Double blind clinical trial on centperazine & DEC in bancroftian filariasis.

Auteurs : R N Rath ; B K Das ; M L Ali ; P K Das ; A C Mishra ; B N Mohapatra

Source :

RBID : pubmed:2228058

Descripteurs français

English descriptors

Abstract

Centperazine, an analogue of DEC, was subjected to a double blind controlled trial, to evaluate its efficacy as a newer antifilarial agent. Centperazine (300 mg/day) along with equivalent quantities of DEC and placebo were administered to different types of filariasis patients. DEC was found to be significantly effective in reducing peripheral microfilaraemia, in different weeks and months of follow-up, except at the end of 6th month, as compared to Centperazine. There was no significant difference between the placebo and Centperazine treated patients, in this respect, revealing that the drugs had no efficacy in eliminating peripheral microfilaraemia. Recurrence of acute attack within 6 months was nearly equal with both Centperazine and DEC, being 28.2 and 24 per cent respectively, whereas in the placebo group the recurrence rate was 48.9 per cent. Centperazine treated patients showed significantly less side effects (8.9%), as compared to DEC treated patients (34%). Giddiness, nausea and vomiting were the common adverse effects observed.

PubMed: 2228058

Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:2228058

Curation

No country items

R N Rath
<affiliation>
<nlm:affiliation>Department of Medicine, S.C.B. Medical College.</nlm:affiliation>
<wicri:noCountry code="subField">S.C.B.</wicri:noCountry>
</affiliation>

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Double blind clinical trial on centperazine & DEC in bancroftian filariasis.</title>
<author>
<name sortKey="Rath, R N" sort="Rath, R N" uniqKey="Rath R" first="R N" last="Rath">R N Rath</name>
<affiliation>
<nlm:affiliation>Department of Medicine, S.C.B. Medical College.</nlm:affiliation>
<wicri:noCountry code="subField">S.C.B.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Das, B K" sort="Das, B K" uniqKey="Das B" first="B K" last="Das">B K Das</name>
</author>
<author>
<name sortKey="Ali, M L" sort="Ali, M L" uniqKey="Ali M" first="M L" last="Ali">M L Ali</name>
</author>
<author>
<name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name>
</author>
<author>
<name sortKey="Mishra, A C" sort="Mishra, A C" uniqKey="Mishra A" first="A C" last="Mishra">A C Mishra</name>
</author>
<author>
<name sortKey="Mohapatra, B N" sort="Mohapatra, B N" uniqKey="Mohapatra B" first="B N" last="Mohapatra">B N Mohapatra</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="1990">1990</date>
<idno type="RBID">pubmed:2228058</idno>
<idno type="pmid">2228058</idno>
<idno type="wicri:Area/PubMed/Corpus">005D39</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">005D39</idno>
<idno type="wicri:Area/PubMed/Curation">005D39</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">005D39</idno>
<idno type="wicri:Area/PubMed/Checkpoint">005D39</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">005D39</idno>
<idno type="wicri:Area/Ncbi/Merge">004A15</idno>
<idno type="wicri:Area/Ncbi/Curation">004A15</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004A15</idno>
<idno type="wicri:doubleKey">0971-5916:1990:Rath R:double:blind:clinical</idno>
<idno type="wicri:Area/Main/Merge">00E632</idno>
<idno type="wicri:Area/Main/Curation">00DA35</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Double blind clinical trial on centperazine & DEC in bancroftian filariasis.</title>
<author>
<name sortKey="Rath, R N" sort="Rath, R N" uniqKey="Rath R" first="R N" last="Rath">R N Rath</name>
<affiliation>
<nlm:affiliation>Department of Medicine, S.C.B. Medical College.</nlm:affiliation>
<wicri:noCountry code="subField">S.C.B.</wicri:noCountry>
</affiliation>
</author>
<author>
<name sortKey="Das, B K" sort="Das, B K" uniqKey="Das B" first="B K" last="Das">B K Das</name>
</author>
<author>
<name sortKey="Ali, M L" sort="Ali, M L" uniqKey="Ali M" first="M L" last="Ali">M L Ali</name>
</author>
<author>
<name sortKey="Das, P K" sort="Das, P K" uniqKey="Das P" first="P K" last="Das">P K Das</name>
</author>
<author>
<name sortKey="Mishra, A C" sort="Mishra, A C" uniqKey="Mishra A" first="A C" last="Mishra">A C Mishra</name>
</author>
<author>
<name sortKey="Mohapatra, B N" sort="Mohapatra, B N" uniqKey="Mohapatra B" first="B N" last="Mohapatra">B N Mohapatra</name>
</author>
</analytic>
<series>
<title level="j">The Indian journal of medical research</title>
<idno type="ISSN">0971-5916</idno>
<imprint>
<date when="1990" type="published">1990</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Animals</term>
<term>Diethylcarbamazine (therapeutic use)</term>
<term>Double-Blind Method</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Filaricides (therapeutic use)</term>
<term>Humans</term>
<term>Middle Aged</term>
<term>Piperazines (therapeutic use)</term>
<term>Wuchereria bancrofti (drug effects)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Diéthylcarbamazine (usage thérapeutique)</term>
<term>Filaricides (usage thérapeutique)</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Humains</term>
<term>Méthode en double aveugle</term>
<term>Pipérazines (usage thérapeutique)</term>
<term>Wuchereria bancrofti ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Diethylcarbamazine</term>
<term>Filaricides</term>
<term>Piperazines</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Wuchereria bancrofti</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en">
<term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr">
<term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Diéthylcarbamazine</term>
<term>Filaricides</term>
<term>Pipérazines</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Adolescent</term>
<term>Adult</term>
<term>Animals</term>
<term>Double-Blind Method</term>
<term>Humans</term>
<term>Middle Aged</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Adolescent</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Animaux</term>
<term>Humains</term>
<term>Méthode en double aveugle</term>
<term>Wuchereria bancrofti</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Centperazine, an analogue of DEC, was subjected to a double blind controlled trial, to evaluate its efficacy as a newer antifilarial agent. Centperazine (300 mg/day) along with equivalent quantities of DEC and placebo were administered to different types of filariasis patients. DEC was found to be significantly effective in reducing peripheral microfilaraemia, in different weeks and months of follow-up, except at the end of 6th month, as compared to Centperazine. There was no significant difference between the placebo and Centperazine treated patients, in this respect, revealing that the drugs had no efficacy in eliminating peripheral microfilaraemia. Recurrence of acute attack within 6 months was nearly equal with both Centperazine and DEC, being 28.2 and 24 per cent respectively, whereas in the placebo group the recurrence rate was 48.9 per cent. Centperazine treated patients showed significantly less side effects (8.9%), as compared to DEC treated patients (34%). Giddiness, nausea and vomiting were the common adverse effects observed.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 00DA35 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 00DA35 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     pubmed:2228058
   |texte=   Double blind clinical trial on centperazine & DEC in bancroftian filariasis.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Curation/RBID.i   -Sk "pubmed:2228058" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024